Multifocal motor neuropathy: Decrease in conduction blocks and reinnervation with long-term IVIg

Neurology

Volumn 63, Issue 7, 2004, Pages 1264-1269

  Vucic, Steve ^a   Black, Kristin R ^a   Chong, Peter Siao Tick ^a   Cros, Didier ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOTHERAPY; LONG TERM CARE; MAINTENANCE DRUG DOSE; MALE; MIDDLE CEREBRAL ARTERY; MOTOR DYSFUNCTION; MOTOR NEUROPATHY; MUSCLE REINNERVATION; MUSCLE STRENGTH; NERVE BLOCK; NERVE CONDUCTION; NERVE FIBER DEGENERATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TRANSIENT ISCHEMIC ATTACK;

EID: 5344241214     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000140497.85952.FA     Document Type: Review

References (32)

1. Parry GJ, Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 1988;11:103-107.
2. Bouche P, Moulonguet A, Younes-Chennoufi AB, et al. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995;59:38-44.
3. Olney RK, Lewis RA, Putnam TD, Campellone JV Jr. American Association of Electrodiagnostic Medicine. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 2003;27:117-121.
4. Nobile-Orazio E. Multifocal motor neuropathy. J Neuroimmunol 2001;2:115:4-18.
5. Donaghy M, Mills KR, Boniface SJ, et al. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1994;57:778-783.
6. Van den Berg LH, Lokhorst H, Wokke JH. Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy. Neurology 1997;48:1135.
7. Meucci N, Cappellari A, Barbieri S, Scarlato G, Nobile-Orazio E. Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 1997;63:765-769.
8. Baker GL, Kahl LE, Zee BC, et al. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study. Am J Med 1987;83:1-9.
9. Levine LA, Richie JP. Urological complications of cyclophosphamide. J Urol 1989;141:1063-1069.
10. Chaudhry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: response to human immune globulin. Ann Neurol 1993;33:237-242.
11. Kermode AG, Laing BA, Carroll WM, Mastaglia FL. Intravenous immunoglobulin for multifocal motor neuropathy. Lancet 1992;340:920-921.
12. Nobile-Orazio E, Meucci N, Barbieri S, Carpo M, Scarlato G. High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993;43:537-544.
13. Azulay JP, Blin O, Pouget J, et al. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study. Neurology 1994;44:429-432.
14. Federico P, Zochodne DW, Hahn AF, Brown WF, Feasby TE. Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology 2000;55:1256-1262.
15. Leger JM, Chassande B, Musset L, et al. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Brain 2001;124:145-153.
16. Van den Berg LH, Kerkhoff H, Oey PL, et al. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. Neurol Neurosurg Psychiatry 1995;59:248-252.
17. Azulay JP, Rihet P, Pouget J, et al. Long term follow up of multifocal motor neuropathy with conduction block under treatment. J Neurol Neurosurg Psychiatry 1997;62:391-394.
18. Van den Berg-Vos RM, Franssen H, Wokke JH, Van den Berg LH. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain 2002;125:1875-1886.
19. Brannagan TH 3rd, Nagle KJ, Lange DJ, Rowland LP. Complications of intravenous immune globulin treatment in neurologic disease. Neurology 1996;47:674-677.
20. Caress JB, Cartwright MS, Donofrio PD, Peacock JE Jr. The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology 2003;60:1822-1824.
21. Dalakas MC. Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med 1997;126:721-730.
22. Kaji R, Oka N, Tsuji T, et al. Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol 1993;33:152-158.
23. Kaji R. Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies. Muscle Nerve 2003;27:285-296.
24. Kiernan MC, Guglielmi JM, Kaji R, Murray NM, Bostock H. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 2002;125:664-675.
25. Van den Berg LH, Franssen H, Wokke JH. The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. Brain 1998;121:421-428.
26. Stys PK, Waxman SG, Ransom BR. Reverse operation of the Na (+)-Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian CNS white matter. Ann NY Acad Sci 1991;639:328-332.
27. Medical Research Council. Aids to the Examination of the Peripheral Nervous System. London: Her Majesty's Stationary Office, 1976:1-2.
28. Brooke MH. A Clinician's View of Neuromuscular Disease. Baltimore: Williams and Wilkins, 1977:18.
29. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
30. Berger AR, Busis NA, Logigian EL, Wierzbicka M, Shahani BT. Cervical root stimulation in the diagnosis of radiculopathy. Neurology 1987;37:329-332.
31. Kimura J. Collision technique. Physiologic block of nerve impulses in studies of motor nerve conduction velocity. Neurology 1976;26:680-682.
32. McCrone P, Chisholm D, Knapp M, et al. Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol 2003;10:687-694.